TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
ANNX

Annexon Inc

Healthcare · Biotechnology

3.80$ -1.8% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow ANNX
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – – – – – – – –
– +80.1% +1.0% +35.3% +221.0% -1.6% +2.0% +0.1% +0.7%
– +1.7% +399.3% +140.0% +232.7% +13.9% -1.8% +6.9% -15.5%
– -63.1% +5,107.4% -35.9% +280.2% -1.4% – – –
– – +30.8% +654.7% -30.4% +13.8% -255.3% – -33.5%
– -97.0% +1,470.6% +73.8% +256.5% +294.6% -97.0% -92.2% +813.3%
– -97.0% +1,470.6% +31,047.6% +6.1% – +21.0% -409.5% –
– – – – – – – – –
– +139,081.0% -48.7% -117.3% – +6,663.0% – – –
– – – – – – – – –
– +139,081.0% -51.4% +1,170.9% -99.5% +6,747.2% +10.3% +19.0% -32.5%
– – -100.6% – -186.2% – +30.8% -306.4% –
– – – – – – – – –

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?